Literature DB >> 16921553

Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs.

Bryan Larsen1, Seth Anderson, Andrea Brockman, Michael Essmann, Martin Schmidt.   

Abstract

The Candida albicans CDR1 gene, encoding an ABC transporter that functions as an efflux pump, is thought to be involved in pathogenic adaptation and uses mammalian hormones and other environmental cues to regulate its activity. Exposure of several clinical isolates of C. albicans to 1 x 10(-8) M 17beta-oestradiol increased CDR1 expression and the isolates showed a positive correlation between oestrogen induction of CDR1 and growth in the presence of oestrogen. A reporter strain carrying the GFP gene under the control of the CDR1 promoter was used to analyse the effect of steroid hormones and antifungal drugs on CDR1 expression by flow cytometry. We found that among the many hormones tested, only oestradiol and progesterone induce CDR1 expression. CDR1 induction requires hormone concentrations greater than 10(-8) M, a threshold reached in vivo only by progesterone. Using the GFP-reporter strain, we show CDR1 induction by female but not male human serum and demonstrate that exposure of C. albicans to physiological concentrations of progesterone measurably increases resistance to fluconazole, miconazole and 5-fluorouracil. Simultaneous exposure of C. albicans to hormones and antifungal drugs provided evidence that both agents induce CDR1 expression via different mechanisms with different saturation points.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16921553     DOI: 10.1002/yea.1394

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  11 in total

1.  Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.

Authors:  Luiz R Basso; Charles E Gast; Yuxin Mao; Brian Wong
Journal:  Eukaryot Cell       Date:  2010-03-26

2.  Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans.

Authors:  Chengjie Shu; Lingmei Sun; Weiming Zhang
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

3.  Sodium choleate (NaCho) effects on Candida albicans: implications for its role as a gastrointestinal tract inhabitant.

Authors:  Bao Vu; Michael Essmann; Bryan Larsen
Journal:  Mycopathologia       Date:  2009-10-30       Impact factor: 2.574

Review 4.  Efflux-mediated antifungal drug resistance.

Authors:  Richard D Cannon; Erwin Lamping; Ann R Holmes; Kyoko Niimi; Philippe V Baret; Mikhail V Keniya; Koichi Tanabe; Masakazu Niimi; Andre Goffeau; Brian C Monk
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 5.  Multidrug Resistance in Mammals and Fungi-From MDR to PDR: A Rocky Road from Atomic Structures to Transport Mechanisms.

Authors:  Narakorn Khunweeraphong; Karl Kuchler
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

6.  Inhibition of Candida albicans by Fluvastatin Is Dependent on pH.

Authors:  Martin Schmidt; Seli Dzogbeta; Michael P Boyer
Journal:  Res Lett Biochem       Date:  2009-08-05

7.  Tetracycline effects on Candida albicans virulence factors.

Authors:  Logan McCool; Hanh Mai; Michael Essmann; Bryan Larsen
Journal:  Infect Dis Obstet Gynecol       Date:  2008

8.  Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.

Authors:  Lingmei Sun; Kai Liao; Dayong Wang
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

9.  Estimation of Candida albicans ABC Transporter Behavior in Real-Time via Fluorescence.

Authors:  Joanna Szczepaniak; Marcin Łukaszewicz; Anna Krasowska
Journal:  Front Microbiol       Date:  2015-12-09       Impact factor: 5.640

10.  Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production.

Authors:  Wenqiang Chang; Ying Li; Li Zhang; Aixia Cheng; Hongxiang Lou
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.